rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Immunotherapy of cancer
  name:
    name part: Disis, Mary L.
  name:
    name part: SpringerLink (Online service)
  type of resource: text
  genre: bibliography
  genre: Electronic books.
  origin info:
    place:
      place term: nju
    date issued: 2006
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: remote
    extent: xii, 516 pages : illustrations ; 26 cm.
  table of contents: Discovery of target molecules for cancer immunotherapy by genetic and bioinformatic approaches -- Current strategies for the identification of immunogenic epitopes of tumor antigens -- Current and future role of natural-killer cells in cancer immunotherapy -- The role of immune monitoring in evaluating cancer immunotherapy -- Statistical analysis of immune response assays -- DNA vaccines for cancer immunotherapy -- Dendritic cells -- Different approaches to dendritic cell-based cancer immunotherapy -- Anti-idiotype antibody vaccines for the immunotherapy of cancer -- Autologous tumor-derived heat shock protein vaccine as a new paradigm for individualized cancer therapeutics -- Tumor-reactive T-cells for adoptive immunotherapy -- T-cell adoptive immunotherapy of cancer: from translational models to clinical significance -- Retroviral-mediated gene transfer for engineering tumor-reactive T-cells -- Harnessing the potential of graft-vs-tumor -- Tumor-induced immune suppression and immune escape: mechanisms and impact on the outcome of immunotherapy of malignant disease -- The tumor microenvironment: regulation of antitumor immunity and implications for immunotherapy -- Manipulation of lymphocyte homeostasis for enhancing antitumor immunity -- Fast-lane evolution in the tumor microenvironment -- Manipulating immunological checkpoints to maximize antitumor immunity -- Interleukin-2 as cancer therapy -- Biological and clinical properties of the type 1 interferons -- Promising g [gamma]-chain cytokines for cancer immunotherapy: interleukins-7, -15, and -21 as vaccine adjuvants, growth factors -- The therapeutic use of natural-killer cells in hematological malignancies -- Antibody therapy for solid tumors -- Antibody therapy for non-Hodgkin's lymphoma -- Approaches to in vivo imaging of cancer immunotherapy -- Design issues for early-stage clinical trials for cancer vaccines -- Monoclonal antibody therapy for cancer.
  note: edited by Mary L. Disis.
  note: Electronic resource.
  note: Electronic reproduction. New York : Springer, 2010. Mode of access: World Wide Web. System requirements: Web browser. Title from title screen (viewed on Aug. 9, 2010). Access may be restricted to users at subscribing institutions.
  note: Mode of access: World Wide Web.
  note: Includes bibliographical references and index.
  subject:
    topic: Immuntherapie
  subject:
    topic: Krebs <Medizin>
  subject:
    topic: Neoplasms
    topic: immunology
  subject:
    topic: Neoplasms
    topic: therapy
  subject:
    topic: Immunotherapy
  subject:
    topic: Antineoplastic agents
    topic: Design
  subject:
    topic: Cancer
    topic: Immunotherapy
  subject:
    topic: Anticancéreux
    topic: Design
  subject:
    topic: Cancer
    topic: Immunothérapie
  classification: RC271.I45 I466 2006
  classification: 616.99/4061
  classification: 2006 B-494
  classification: QZ 266 I33 2006
  related item:
    identifier: (DLC) 2005017065
    identifier: (OCoLC)60651107
  related item:
    title info:
      title: Cancer drug discovery and development
  identifier: 1588295648 (alk. paper)
  identifier: 1597450111
  identifier: 9781588295644 (alk. paper)
  identifier: 9781597450119
  identifier: 978-1-58829-564-4 Springer
  identifier: http://proxy.library.tamu.edu/login
  record info:
    record content source: GW5XE
    record creation date: 100813
    record change date: 20210727154925.0
    record identifier: in00002653666
    language of cataloging:
      language term: eng